Is Immunotherapy Living Up to Its Promise?

The Scientist is bringing together a panel of experts to weigh in on the progress that immunotherapy has made.

By The Scientist Creative Services Team | July 19, 2017

Is Immunotherapy Living up to Its Promise? from thescientistllc on Vimeo

Immunotherapy has been hailed as a breakthrough for treating the untreatable, but it has not yet lived up to its promise to eradicate cancer and infectious disease. While there have been a number of exciting advances, there are still several real-world hurdles for immunotherapy to surmount before it becomes a standard option for most patients. The Scientist is bringing together a panel of experts to weigh in on the progress that immunotherapy has made, particularly in the search for effective anticancer treatments, and to discuss the steps still needed before immunotherapy becomes standard treatment in the clinic. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics that are related to their research.

Topics to be covered:

  • Where immunotherapies have succeeded, and where they have failed
  • Current progress in immunotherapy research, development, and deployment

View the Video Now

Meet the Speakers:

Jill O’Donnell-Tormey, PhD
CEO and Director of Scientific Affairs
Cancer Research Institute





Alex Y. Huang, MD, PhD
Professor, Departments of Pediatrics,
Pathology, Biomedical Engineering,
and General Medical Sciences,
Case Western Reserve University School of Medicine,
UH Rainbow Babies & Children's Hospital




Beckman Coulter

Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Two University of Rochester Professors Resign in Protest
  2. Dartmouth Professor Investigated for Sexual Misconduct Retires
  3. Theranos Leaders Indicted For Fraud
    The Nutshell Theranos Leaders Indicted For Fraud

    Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.

  4. Koko the Signing Gorilla Dies at 46